Oxford Launches World’s First Human Trial of Bundibugyo Ebola Vaccine
The University of Oxford has launched the world’s first Phase I clinical trial of a vaccine specifically designed to protect […]
Ebola
The Outbreak That Wouldn’t Die: Ebola
Epidemiologists have found that recent Ebola outbreaks may be linked to the virus re-emerging from human survivors rather than from wildlife. The virus can persist in immune-protected sites, notably semen, for months. A significant percentage of survivors experience long-term health effects, necessitating continued surveillance and testing for ongoing transmission risks.
Why there is still no Universal Ebola Vaccine
Ebola vaccine development has made major progress, moving from experimental research to licensed vaccines and real-world outbreak control. Yet important challenges remain, including limited protection across all Ebola species, uncertain durability of immunity, and the difficulty of testing vaccines during unpredictable outbreaks.
Ebola Outbreak Timeline: History, Major Epidemics and Global Impact (1976–2026)
A new Ebola outbreak linked to the rare Bundibugyo strain has emerged in the Democratic Republic of Congo and Uganda, prompting the World Health Organization to declare a public health emergency. With rising suspected cases, deaths, and concerns over cross-border transmission, health authorities are intensifying surveillance, testing, and containment efforts across the region.